Clinical Trials Directory

Trials / Unknown

UnknownNCT01335815

High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Total Endoprosthesis

High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Knee and Hip Endoprosthesis

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Summary: The purpose of the study is to prove if the biomarker high sensitive troponin T (hsTnT) and the biomarker of endogenous stress copeptin can serve as surrogate parameter of prognosis in patients with elective knee and hip total endoprosthesis.

Detailed description

Consecutively, high sensitive troponin T and copeptin will be measured in all patients with elective knee and hip endoprosthesis in the orthopedic department of the University of Heidelberg. The blood is taken during the routine blood testes if possible, on admission and the days 1-4 following the operation. Usual baseline characteristics are taken as well as usual blood results (hb, cholesterol and so on). Primary endpoint is the detection of perioperative myocardial infarction and pulmonary embolism.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2012-03-01
Completion
2013-03-01
First posted
2011-04-14
Last updated
2011-04-14

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01335815. Inclusion in this directory is not an endorsement.